BPTH(Delisted)
Bio-Path HoldingsยทNASDAQ
--
--(--)
BPTH Profile
Bio-Path Holdings, Inc.
A biotechnology company that develops a portfolio of targeted nucleic acid cancer drugs
4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401
--
Bio-path Holdings, Inc. The company was founded on May 10, 2007. The company is a clinical and preclinical stage RNAi nanoparticle drug development company focused on oncology, utilizing a new technology for whole-body delivery for target-specific protein inhibition of any gene product that is overexpressed in disease.
